KBI BioPharma Overview
- Year Founded
-
1996
- Status
-
Acquired/Merged
- Employees
-
1,622
- Latest Deal Type
-
M&A
- Investors
-
2
KBI BioPharma General Information
Description
Provider of biopharmaceutical contract services intended to facilitate the smooth functioning of the biopharmaceutical industry. The company provides fully-integrated, accelerated drug development and biomanufacturing services to pharmaceutical and biotechnology companies globally, enabling the medical industry to accelerate their drug development programs.
Contact Information
Website
www.kbibiopharma.com(Operating Subsidiary)
Corporate Office
- 4117 Emperor Boulevard
- Durham, NC 27703
- United States
Corporate Office
- 4117 Emperor Boulevard
- Durham, NC 27703
- United States
KBI BioPharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 23-Mar-2015 | Completed | Profitable | |||
| 6. Accelerator/Incubator | Completed | Profitable | ||||
| 5. Later Stage VC | 23-Sep-2009 | Completed | Profitable | |||
| 4. Later Stage VC | 27-Feb-2009 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 04-Sep-2008 | Completed | Generating Revenue | |||
| 2. Later Stage VC (Series B) | 05-Dec-2005 | $6M | $9.7M | Completed | Startup | |
| 1. Later Stage VC | 05-Jan-2005 | $3.69M | $3.69M | Completed | Startup |
KBI BioPharma Comparisons
Industry
Financing
Details
KBI BioPharma Competitors (16)
One of KBI BioPharma’s 16 competitors is Lonza Group, a Corporation company based in Basel, Switzerland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Lonza Group | Corporation | Basel, Switzerland | ||||
| AGC Biologics | Formerly VC-backed | Bothell, WA | ||||
| AAPharmaSyn | Corporation | Ann Arbor, MI | ||||
| Fujifilm Diosynth Biotechnologies | Corporate Backed or Acquired | College Station, TX | ||||
| Jubilant Pharmova | Corporation | Noida, India |
KBI BioPharma Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
KBI BioPharma Patents
KBI BioPharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3334749-A1 | Non-chromatographic separation of polypeptides using the combination of a steric exclusion agent and a charge neutralization agent | Inactive | 14-Aug-2015 | ||
| EP-3334749-A4 | Non-chromatographic separation of polypeptides using the combination of a steric exclusion agent and a charge neutralization agent | Inactive | 14-Aug-2015 | ||
| US-20190002495-A1 | Non-chromatographic separation of polypeptides using the combination of a steric exclusion agent and a charge neutralization agent | Inactive | 14-Aug-2015 | ||
| WO-2017030960-A1 | Non-chromatographic separation of polypeptides using the combination of a steric exclusion agent and a charge neutralization agent | Inactive | 14-Aug-2015 | ||
| US-10570380-B2 | Downstream processing of an alkaline phosphatase | Active | 24-Jan-2014 | C12N9/16 |
KBI BioPharma Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
KBI BioPharma Former Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Ballast Point Partners | Growth/Expansion | Minority | ||
| Capital Southwest | PE/Buyout | Minority | ||
| IDM Partners | Infrastructure | Minority | ||
| LINK-J | Accelerator/Incubator | |||
| North Carolina Biotechnology Center | Not-For-Profit Venture Capital | Minority |
KBI BioPharma Investments & Acquisitions (8)
KBI BioPharma’s most recent deal was a Later Stage VC with Absci for . The deal was made on 26-Nov-2019.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Absci | 26-Nov-2019 | Later Stage VC | Drug Discovery | ||
| Comera Life Sciences Holdings | 04-Apr-2018 | Early Stage VC | Biotechnology | ||
| Elion Labs | 22-Jan-2018 | Merger/Acquisition | Laboratory Services (Healthcare) | ||
| GlycoSeLect | 27-Oct-2017 | Seed Round | Biotechnology | ||
| Alliance Protein Laboratories | 01-Jul-2017 | Merger/Acquisition | Other Healthcare Services |
KBI BioPharma FAQs
-
When was KBI BioPharma founded?
KBI BioPharma was founded in 1996.
-
Where is KBI BioPharma headquartered?
KBI BioPharma is headquartered in Durham, NC.
-
What is the size of KBI BioPharma?
KBI BioPharma has 1,622 total employees.
-
What industry is KBI BioPharma in?
KBI BioPharma’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is KBI BioPharma a private or public company?
KBI BioPharma is a Private company.
-
What is KBI BioPharma’s current revenue?
The current revenue for KBI BioPharma is .
-
How much funding has KBI BioPharma raised over time?
KBI BioPharma has raised $28M.
-
Who are KBI BioPharma’s investors?
Ballast Point Partners, Capital Southwest, IDM Partners, LINK-J, and North Carolina Biotechnology Center are 5 of 8 investors who have invested in KBI BioPharma.
-
Who are KBI BioPharma’s competitors?
Lonza Group, AGC Biologics, AAPharmaSyn, Fujifilm Diosynth Biotechnologies, and Jubilant Pharmova are some of the 16 competitors of KBI BioPharma.
-
When was KBI BioPharma acquired?
KBI BioPharma was acquired on 23-Mar-2015.
-
Who acquired KBI BioPharma?
KBI BioPharma was acquired by JSR.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
